Development and validation of a risk prediction model for overall survival in patients with nasopharyngeal carcinoma: a prospective cohort study in China

被引:9
作者
Miao, Siwei [1 ]
Lei, Haike [2 ]
Li, Xiaosheng [2 ]
Zhou, Wei [2 ]
Wang, Guixue [3 ]
Sun, Anlong [2 ]
Wang, Ying [2 ]
Wu, Yongzhong [2 ]
机构
[1] Chongqing Med Univ, Sch Publ Hlth, Dept Hlth Stat, Chongqing 400016, Peoples R China
[2] Chongqing Univ, Canc Hosp, Chongqing Canc Multiom Big Data Applicat Engn Res, Chongqing 400030, Peoples R China
[3] Chongqing Univ, Coll Bioengn, MOE Key Lab Biorheol Sci & Technol, State & Local Joint Engn Lab Vasc Implants, Chongqing 400030, Peoples R China
关键词
Nasopharyngeal carcinoma; Nomogram; Overall survival; Prognosis; TO-LYMPHOCYTE RATIO; PROGNOSTIC VALUE; BIOMARKERS;
D O I
10.1186/s12935-022-02776-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Nasopharyngeal carcinoma (NPC) is prevailing in Southern China, characterized by distinct geographical distribution. Aimed to predict the overall survival (OS) of patients with nasopharyngeal carcinoma, this study developed and validated nomograms considering demographic variables, hematological biomarkers, and oncogenic pathogens in China. Methods: The clinicopathological and follow-up data of the nasopharyngeal carcinoma patients obtained from a prospective longitudinal cohort study in the Chongqing University Cancer Hospital between Jan 1, 2017 and Dec 31, 2019 (n = 1635). Cox regression model was used to tested the significance of all available variables as prognostic factors of OS. And independent prognostic factors were identified based on multivariable analysis to model nomogram. Concordance index (C-index), area under the receiver operating characteristic (AUC), calibration curve, and decision curve analysis (DCA) were measured to assess the model performance of nomogram. Results: Data was randomly divided into a training cohort (1227 observers, about 70% of data) and a validation group (408 observers, about 30% of data). At multivariable analysis, the following were independent predictors of OS in NPC patients and entered into the nomogram: age (hazard ratio [HR]: 1.03), stage (stage IV vs. stage I-II, HR: 4.54), radiotherapy (Yes vs. No, HR: 0.43), EBV (>= 1000 vs.< 1000, HR: 1.92), LAR (> 6.15 vs.<= 6.15, HR: 2.05), NLR (> 4.84 vs. <= 4.84 HR: 1.54), and PLR (> 206.33 vs.<= 206.33, HR: 1.79). The C-indexes for training cohort at 1-, 3- and 5-year were 0.73, 0.83, 0.80, respectively, in the validation cohort, the C-indexes were 0.74 (95% CI 0.63-0.86), 0.80 (95% CI 0.73-0.87), and 0.77 (95% CI 0.67-0.86), respectively. The calibration curve demonstrated that favorable agreement between the predictions of the nomograms and the actual observations in the training and validation cohorts. In addition, the decision curve analysis proved that the nomogram model had the highest overall net benefit. Conclusion: A new prognostic model to predict OS of patients with NPC was developed. This can offer clinicians treatment making and patient counseling. Furthermore, the nomogram was deployed into a website server for use.
引用
收藏
页数:11
相关论文
共 50 条
[41]   An overall survival predictive nomogram to identify high-risk patients among locoregionally advanced nasopharyngeal carcinoma: Developed based on the SEER database and validated institutionally [J].
Lin, Yinbing ;
Chen, Jiechen ;
Wang, Xiao ;
Chen, Sijie ;
Yang, Yizhou ;
Hong, Yingji ;
Lin, Zhixiong ;
Yang, Zhining .
FRONTIERS IN ONCOLOGY, 2023, 13
[42]   Nasopharyngeal necrosis contributes to overall survival in nasopharyngeal carcinoma without distant metastasis: a comprehensive nomogram model [J].
Xue-Song Sun ;
Zhi-Wen Xiao ;
Sai-Lan Liu ;
Rui Sun ;
Dong-Hua Luo ;
Qiu-Yan Chen ;
Hai-Qiang Mai .
European Radiology, 2023, 33 :3682-3692
[43]   Association of public health insurance with cancer-specific mortality risk among patients with nasopharyngeal carcinoma: a prospective cohort study in China [J].
Li, Dan ;
Lei, Hai-Ke ;
Shu, Xiao-Lei ;
Zhang, Xin ;
Tu, Hong-Lei ;
Wang, Feng ;
Wang, Yu-Wei ;
Wang, Ying ;
Sui, Jiang-Dong .
FRONTIERS IN PUBLIC HEALTH, 2023, 11
[44]   Development and Validation of a Prognostic Model to Predict Overall Survival in Multiple System Atrophy [J].
Eschlboeck, Sabine ;
Goebel, Georg ;
Eckhardt, Christine ;
Fanciulli, Alessandra ;
Raccagni, Cecilia ;
Boesch, Sylvia ;
Djamshidian, Atbin ;
Heim, Beatrice ;
Mahlknecht, Philipp ;
Mair, Katherina ;
Nachbauer, Wolfgang ;
Scherfler, Christoph ;
Stockner, Heike ;
Poewe, Werner ;
Seppi, Klaus ;
Kiechl, Stefan ;
Wenning, Gregor ;
Krismer, Florian .
MOVEMENT DISORDERS CLINICAL PRACTICE, 2023, 10 (09) :1368-1376
[45]   Nomogram Model for Predicting the Overall Survival of Patients With Meningiomas: a Retrospective Cohort Study [J].
Cai, Linqiang ;
Yang, Zhihao ;
Song, Dagang ;
Luo, Ming .
WORLD NEUROSURGERY, 2023, 171 :E309-E322
[46]   Development and validation of a prognostic model based on metabolic risk score to predict overall survival of endometrial cancer in Chinese patients [J].
Li, Xingchen ;
Yang, Xiao ;
Cheng, Yuan ;
Dong, Yangyang ;
Wang, Jingyuan ;
Wang, Jianliu .
JOURNAL OF GYNECOLOGIC ONCOLOGY, 2023, 34 (06)
[47]   Development and Validation of a Prognostic Model for Predicting Overall Survival in Patients With Bladder Cancer: A SEER-Based Study [J].
Wang, Wei ;
Liu, Jianchao ;
Liu, Lihua .
FRONTIERS IN ONCOLOGY, 2021, 11
[48]   Development and validation of a nomogram for predicting the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms [J].
Xie, Si ;
Li, Lei ;
Wang, Xiaotong ;
Li, Lequn .
MEDICINE, 2021, 100 (02) :E24223
[49]   A novel prognostic model predicts overall survival in patients with nasopharyngeal carcinoma based on clinical features and blood biomarkers [J].
Lai, Changchun ;
Zhang, Chunning ;
Lv, Hualiang ;
Huang, Hanqing ;
Ke, Xia ;
Zhou, Chuchan ;
Chen, Hao ;
Chen, Shulin ;
Zhou, Lei .
CANCER MEDICINE, 2021, 10 (11) :3511-3523
[50]   Development and validation of a risk prediction model for tigecycline-induced hypofibrinogenemia in septic patients: a retrospective cohort study [J].
Hongling Ma ;
Zhaotang Gong ;
Jia Sun ;
LiNa Chen ;
GuLeng SiRi .
BMC Infectious Diseases, 25 (1)